Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Monjuvi
Generic name : Tafasitamab
Manufactured By : Morphosys Us Inc
Indications : Relapsed or refractory Diffuse large B CELL lymphoma
Medicine Description : Monjuvi is an anti-CD19 monoclonal antibody for relapsed/refractory diffuse large B-cell lymphoma (DLBCL). It enhances immune system activity against cancer cells. Given via IV infusion, it improves survival. Side effects include fatigue, infections, infusion reactions, and low blood counts. Blood count monitoring helps manage side effects.
Monjuvi Medicine (Tafasitamab) is a prescription drug used to treat adults with diffuse large B-cell lymphoma (DLBCL) who cannot undergo a stem cell transplant.
Monjuvi is a monoclonal antibody that targets the CD19 protein on cancer cells, helping the immune system destroy them.
Doctors prescribe Monjuvi for adults with relapsed or refractory DLBCL, often in combination with lenalidomide.
Monjuvi is given as an intravenous (IV) infusion by a healthcare provider, usually on specific days of a treatment cycle.
Common side effects include fatigue, low blood cell counts, fever, diarrhea, cough, and infections.
Yes, Monjuvi may cause severe infections, infusion-related reactions, or bone marrow suppression. Consult your doctor if serious symptoms occur.
Monjuvi treatment continues as long as it is effective and well-tolerated, or until a doctor advises stopping.
It is best to avoid alcohol while on Monjuvi, as it may increase the risk of liver issues and worsen side effects.
No, Monjuvi may harm an unborn baby. Women should use effective contraception during and after treatment.
Yes, Monjuvi may interact with other drugs, especially those that affect the immune system or blood cells. Inform your doctor of all medications you take.
If you miss an infusion, contact your healthcare provider to reschedule as soon as possible.
Since Monjuvi is given as an IV infusion, food does not directly impact its administration.
Monitor for infections, avoid live vaccines, and follow your doctor’s recommendations for regular blood tests.
Monjuvi is stored in a medical facility under controlled conditions. Patients do not need to store it at home.
Monjuvi is available by prescription and administered in hospitals or specialized treatment centers. Consult your doctor for details. Pharma Five assists in its procurement.